Companies: 10,795·Total market cap: $144.5T
NeutriSci International Inc.

NeutriSci International Inc.

NRXCFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$653980
P/E Ratio
52W High$0.0013
52W Low$0.0013

NeutriSci International Inc.(NRXCF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NRXCF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$0.46M$0.08M$0.07M$0.10M$0.08M
Cost of Revenue$0.50M$0.10M$0.08M$0.09M$0.08M
Gross Profit($0.04M)($0.02M)($0.01M)$0.00M$0.00M
Gross Margin %(computed)-9.48%-25.40%-7.87%3.04%4.73%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
G&A Expenses$0.60M$1.25M$1.71M$1.42M$1.72M
Total Operating Expenses$0.65M$1.37M$1.94M$1.65M$2.28M
Operating Income($0.69M)($1.50M)($1.94M)($1.65M)($2.26M)
Operating Margin %(computed)-150.81%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($0.77M)($1.57M)($1.95M)($1.61M)($2.38M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.02M
Net Income($0.77M)($1.57M)($1.95M)($1.61M)($2.38M)
Net Margin %(computed)-168.37%
Per Share & EBITDA
EPS (Basic)$-0.00$-0.01$-0.01$-0.01$-0.02
Wtd Avg Shares166.15M158.59M143.38M116.02M101.66M
EBITDA($0.73M)($1.53M)($1.92M)($1.61M)($2.36M)
EBITDA Margin %(computed)-160.23%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CAD · M

深入了解NeutriSci International Inc.

关于NeutriSci International Inc.(NRXCF)损益表

NeutriSci International Inc.(NRXCF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,NRXCF实现营收$0.00B,毛利润($0.00B)(毛利率-9.48%),净利润($0.00B)(净利率-168.37%)。

常见问题

NRXCF · 4 问

NeutriSci International Inc.(NRXCF)2022财年营收为$0.00B,同比up465.9%。

NRXCF revenueNRXCF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09